RxDoctor Payments Data

Ravinder Mediratta, MD

Psychiatry · Portage, MINPI 1003991191

Payments from drug & device makers

$8,049in general payments, 2019–2025

Across 46 payments — averaging $174.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$8K
  • Supernus Pharmaceuticals, Inc.$132
  • Teva Pharmaceuticals USA, Inc.$111
  • E.r. Squibb & Sons, L.L.C.$60
  • Alkermes, Inc.$58
  • Indivior Inc.$41
  • plus $139 from 7 others

What the payments were for

  • Consulting fees$6,24078%
  • Travel & lodging$78510%
  • Food & beverage$90611%
  • Education$1191%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,049 in reported general payments places this provider in the 90th percentile of 1,166 psychiatry providers in Michigan.

See all psychiatry providers in Michigan

Medicare billing

Part B allowed, 2024
$72,468
Medicare patients
69
Services billed
925

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SpravatoEsketamine Hcl41$131,952
RexultiBrexpiprazole12$16,942
InvegaPaliperidone26$10,972
Desvenlafaxine Succinate ErDesvenlafaxine Succinate134$5,639
Duloxetine Hcl193$4,896
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine173$4,555
DayvigoLemborexant12$3,964
Bupropion XlBupropion Hcl145$3,911
Quetiapine Fumarate153$3,520
Ziprasidone Hcl94$3,224
Alprazolam ErAlprazolam49$2,895
Fluvoxamine Maleate63$2,606
Vilazodone Hcl38$2,582
Trazodone Hcl270$2,502
Alprazolam506$2,467

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonSpravato, Invega$7,509$142,92567 claims
Otsuka America Pharmaceutical, Inc.Rexulti$15$16,94212 claims
Eisai Inc.Dayvigo$17$3,96412 claims
Almatica Pharma LLCSertraline Hcl$16$1,562134 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,166 psychiatry providers in Michigan.

Other psychiatry in Portage

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →